Abstract: A portable bioreactor is provided. The portable bioreactor may comprise: a frame unit; a cell culture unit which has one side mounted to the frame unit and in which a plurality of supports for cell culture are arranged, the cell culture unit being provided with an inlet, through which a medium supplied from the outside flows in, and an outlet, through which the medium inside the cell culture unit is discharged to the outside, a medium adjustment unit installed in the frame unit and storing therein a certain amount of medium for the cell culture; a circulation pump installed and fixed to the frame unit to circulate the medium stored in the medium adjustment unit; and a gas supply unit for supplying gas to the medium adjustment unit to maintain the medium stored in the medium adjustment unit at a constant pH.

Abstract: A heat pump system for a vehicle is provided to improve cooling and heating performance by applying a gas injection device selectively operating during air conditioning of a vehicle interior by increasing a flow rate of the refrigerant circulating in a refrigerant line of the heat pump system. The heat pump system for a vehicle may include: a compressor, a first condenser, a receiver dryer, a second condenser, an evaporator, a gas injection device, a refrigerant connection line, and a chiller. The flow of the refrigerant is controlled according to at least one mode for adjusting a temperature of a vehicle interior or adjusting a temperature of a battery module.

Abstract: A structure for increasing durability of an ion filter, which includes a reservoir configured to store cooling water discharged from a fuel cell stack, an ion filter configured to remove ions from the cooling water discharged from the fuel cell stack, a flow rate adjustment valve disposed between the ion filter and the fuel cell stack, a first pipe which flows the cooling water from the ion filter to the reservoir, and a second pipe that is a passage through which air or the cooling water is moved between the reservoir and the ion filter according to a change in level of the cooling water inside the ion filter.

Abstract: A heat pump system for a vehicle is provided to efficiently perform heating of a vehicle interior in a state in which the external temperature is low and heat generated by a heating element is not sufficient in an early stage of driving the vehicle. The heat pump system may include: a compressor; a heat, ventilation, and air condition (HVAC) module; a heat-exchanger; a first expansion valve; an accumulator; a first connection line; a chiller; and a second expansion valve.

Abstract: A thin film transistor includes a first gate electrode on a substrate, a gate insulating film on the first gate electrode, a first active layer on the gate insulating film, a drain electrode on one side of the first active layer, a sidewall spacer on a side wall of the drain electrode, and a first source electrode provided on the other side of the first active layer and a sidewall of the sidewall spacer.

Abstract: The semiconductor memory device including a bit line in a first direction on a substrate, a channel structure on the bit line, and including a first vertical part in a second direction, and a second vertical part apart from the first vertical part in the first direction and in the second direction, a back-gate electrode on the bit line on a side of the channel structure and in the second direction, a back-gate insulating film between the back-gate electrode and the channel structure, a back-gate capping film on the back-gate electrode and the back-gate insulating film, a first and second word lines between the first and the second vertical parts and in the second direction, the second word line spaced apart from the first word line in the first direction and first and second capacitors connected to the first and second vertical parts, on the first and second vertical parts.

Abstract: The present invention relates to a pharmaceutical composition for treating STK11-mutation cancer, containing, as an active ingredient, a material inhibiting a sodium-potassium transport function of Na+—K+ ATPase (ATP1A1); an anticancer drug containing the composition as an active ingredient; and a method for screening STK11-mutation cancer therapeutic agent. It was first established that, of cancer cells in which various gene mutations are confirmed, an STK11-mutation cancer cell line, which is confirmed at high frequency, was treated with cardiac glycosides as a material inhibiting a sodium-potassium transport function of Na+—K+ ATPase (ATP1A1), to significantly inhibit the growth of cancer cells. Therefore, the material inhibiting a sodium-potassium transport function of Na+—K+ ATPase (ATP1A1) can be a target for treating SK11-mutation-derived cancer.

Abstract: The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating cancer including a lignan compound having a specific chemical structure (Chemical Formula 1); a health functional food composition for preventing or ameliorating cancer including the lignan compound; and a method for preventing, ameliorating, or treating cancer using the composition. Further, the present invention relates to a use of the lignan compound in the preparation of a pharmaceutical composition or a health functional food composition for preventing, ameliorating, or treating cancer.

Abstract: Provided are a coupon apparatus, user equipment, a service providing device, a control method thereof, and a non-transitory computer readable storage medium having computer program recorded thereon. That is, according to the present invention, it is possible to issue a coupon in a non-affiliated store and improve convenience of a user by easily issuing the coupon, by issuing the coupon according to a real-time sales situation of the store by a simple operation in a non-affiliated/affiliated store.

Abstract: According to an embodiment of the present invention, a method for issuing a user certificate of a verification server comprises: receiving a user certificate issue request including a user ID from a user terminal; receiving a user public key, a biometric identification replacement code, and hardware identification information generated by the user terminal; and generating a user certificate including the user ID, the user public key, and certificate information; and encrypting the user certificate generated and transmitting it to the user terminal, is provided.

Abstract: The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating cancer including a lignan compound having a specific chemical structure (Chemical Formula 1); a health functional food composition for preventing or ameliorating cancer including the lignan compound; and a method for preventing, ameliorating, or treating cancer using the composition. Further, the present invention relates to a use of the lignan compound in the preparation of a pharmaceutical composition or a health functional food composition for preventing, ameliorating, or treating cancer.

Abstract: Compositions and methods for treating, preventing, or ameliorating one or more symptoms, disorders, or conditions associated with particular c-Jun N-terminal kinase(s) (JNKs) activity are provided. Compositions contain small molecules such as pyrazoloanthrones.